Back to News
Feb 2, 2026 12:01 PM

KabaFusion and Nautic Partners Announce Completion of Significant Growth Investment

LEXINGTON, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- KabaFusion (the "Company"), a nationally recognized leader in home and alternative site infusion, and Nautic Partners ("Nautic") announced today that Nautic has completed its growth investment in KabaFusion. KabaFusion's clinician-led management team remains significant investors and will continue to lead the Company, while Novo Holdings exited its successful investment in the Company.

Headquartered in Cerritos, CA and Lexington, MA, KabaFusion was founded in 2010 by Chief Executive Officer Dr. Sohail Masood, a pioneer in patient-focused intravenous immunoglobulin (IVIG) infusion therapies with more than three decades of clinical experience. Today, KabaFusion is licensed to serve patients in 45 states through its expansive network of 33 infusion pharmacies and 21 ambulatory infusion suites. This new growth partnership with Nautic will enable the Company to accelerate and further expand its mission to serve patients, healthcare practitioners, and payers nationwide with the highest quality home infusion services and unmatched clinical excellence.

Dr. Sohail Masood, CEO and Founder of KabaFusion, said, "We are thrilled to ...